Key clinical point: Biotin supplementation may have therapeutic potential for patients with inflammatory bowel disease (IBD).
Major finding: In mice, biotin supplementation delayed onset of colitis, minimized pathology, and accelerated healing.
Study details: An inflammatory bowel disease mouse model study.
Disclosures: The study was funded by the Veteran’s Administration and the National Institutes of Health. The investigators reported no conflicts of interest.
Skupsky J et al. Cell Mol Gastroenterol Hepatol. 2019 Nov 28. doi: 10.1016/j.jcmgh.2019.11.011.